Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InMed Pharmaceuticals (INM) Non-cash Items (2023 - 2025)

Historic Non-cash Items for InMed Pharmaceuticals (INM) over the last 3 years, with Q4 2025 value amounting to $161372.0.

  • InMed Pharmaceuticals' Non-cash Items rose 1787.67% to $161372.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $161372.0, marking a year-over-year increase of 1787.67%. This contributed to the annual value of $72549.0 for FY2025, which is 6068.64% down from last year.
  • InMed Pharmaceuticals' Non-cash Items amounted to $161372.0 in Q4 2025, which was up 1787.67% from $50055.0 recorded in Q3 2025.
  • InMed Pharmaceuticals' Non-cash Items' 5-year high stood at $1.3 million during Q4 2023, with a 5-year trough of $42297.0 in Q3 2023.
  • Its 3-year average for Non-cash Items is $317419.8, with a median of $117952.5 in 2024.
  • Its Non-cash Items has fluctuated over the past 5 years, first soared by 8602.97% in 2024, then tumbled by 9096.73% in 2025.
  • InMed Pharmaceuticals' Non-cash Items (Quarter) stood at $1.3 million in 2023, then crashed by 89.07% to $136899.0 in 2024, then increased by 17.88% to $161372.0 in 2025.
  • Its Non-cash Items was $161372.0 in Q4 2025, compared to $50055.0 in Q3 2025 and $72549.0 in Q2 2025.